Author Archives

Just read about a phase 3 Melanoma treatment study today, a “Takeover Target”. I’m not a subscriber to Takeover Targets. He says this company is likely a takeover target by Astra Zeneca, and they are already partnered with Astra Zeneca. It’s a therapy which makes a treatment out of your own tumor. I have a […]

Recent Author Comments

On Microblog: Dylan Jovine's Melanoma Teaser

Have been researching Dylan Jovine's Takeover Target and it looks like Iovance Biotherapeutics. (IOVA). Would love to hear some thoughts on it....[...]

Go to Comment »
On Microblog: Non-opioid painkiller using Tolperisone; Neurana Pharmaceuticals

Also I forgot to mention that Neurana is partnered with Sanochemia Pharmazeutika (Austria) using their drug, Tolperisone. Sanochemia is not public either, I believe. From Sanochemia's website:Neurology Tolperisone is a muscle relaxant developed for the tr[...]

Go to Comment »
On Microblog: Cambridge Massachussets small cap biotech company called EDITAS. Drug : AGN-151587 FDA fast track ref EDIT-101 : cure genetic blindness LCA10 using Crispr Genome editing tech

I watched that video. I researched as well and was pretty convinced the company he was referencing was Editas. I took a chance and bought a sizeable chunk of the stock, and am glad I did. However, the news that the stock surged on had to do with sickle ce[...]

Go to Comment »
On Microblog: Jeffery Brown's latest recommendation?

My educated guess is Editas. I'm all but certain. Look at my postings on Redditt.[...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info